In syngeneic mouse models of gastric cancer, PCSK9 inhibition was demonstrated to upregulate DC infiltration and tumor cell MHC-II expression and subsequently enhance CD8+ T cell activation to realize potent tumor repression. Here, PCSK9 is linked to neoplasm.